Invention Application
US20080293744A1 Enantiomers of Selected Fused Pyrimidones and Uses in the Treatment and Prevention of Cancer
审中-公开
所选融合嘧啶酮及其用途在治疗和预防癌症中的对映体
- Patent Title: Enantiomers of Selected Fused Pyrimidones and Uses in the Treatment and Prevention of Cancer
- Patent Title (中): 所选融合嘧啶酮及其用途在治疗和预防癌症中的对映体
-
Application No.: US11573683Application Date: 2005-08-16
-
Publication No.: US20080293744A1Publication Date: 2008-11-27
- Inventor: Brian Aquila , Michael Howard Block , Audrey Davies , Jayachandran Ezhuthachan , Timothy Pontz , Daniel John Russell , Marie-Elena Theoclitou , XiaoLan Zheng
- Applicant: Brian Aquila , Michael Howard Block , Audrey Davies , Jayachandran Ezhuthachan , Timothy Pontz , Daniel John Russell , Marie-Elena Theoclitou , XiaoLan Zheng
- Applicant Address: SE Sodertalje
- Assignee: ASTRAZENECA AB
- Current Assignee: ASTRAZENECA AB
- Current Assignee Address: SE Sodertalje
- International Application: PCT/GB2005/003207 WO 20050816
- Main IPC: A61K31/519
- IPC: A61K31/519 ; C07D513/04 ; A61P35/00
Abstract:
This invention relates to novel compounds having the structural formula (I) and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment or prophylaxis of cancer.
Information query
IPC分类:
